ERBB2 and neoplasm: In univariate analysis, factors that could be associated with DFS, including age, menopausal status, histology, grade, tumor location, cT stage, cN stage, stage at diagnosis, Ki-67 index, HER2 status, HR status, chemotherapy types, a present dose-dense regimen, and pCR rates, were tested.